Plain-English translation of NCT05732077 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a measurement called fractional flow reserve (FFR) can help doctors decide which patients with high blood pressure caused by kidney artery narrowing should receive a stent—a small tube placed in the artery to improve blood flow. Some patients benefit from stents even though large studies suggest they don't help everyone. The researchers want to see if FFR can identify exactly which patients will benefit most.
Large clinical trials have shown that stents don't always help patients with kidney artery narrowing, but many patients in real-world practice do improve after receiving one. Right now, doctors don't have a clear standard test to determine who should and shouldn't get a stent, so this trial is exploring whether FFR—a measurement already proven useful in heart disease—could help make that decision for kidney arteries too.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have a kidney artery procedure where doctors place a catheter (thin tube) and measure blood flow using FFR. Some participants will receive a stent based on their FFR measurement, while others may not need one. After the procedure, your blood pressure will be monitored at 3 months and you will be followed for 1 year total, with visits to check how well your blood pressure is controlled and how your kidneys are functioning.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China